File Archive - Addiction Documents - Glutamatergic substrates of drug addiction and alcoholism (2008) - Drugs Forum
Drugs-Forum  
News Groups Blog Forum Chat Video Audio Images Documents Wiki Home
Go Back   Drugs Forum > File Archive > Documents > VARIOUS DRUG RELATED TOPICS > Addiction Documents
Register Tags Mark Forums Read

Notices

Search
links

 
Addiction Documents
Documents about addiction
New entries announced in forum Recovery and addiction
Allowances: 4.88 Mbytes/302.80 Kbytes used

  Entries
  Glutamatergic substrates of drug addiction and alcoholism (2008) Left click: open entry/Right click: save entry
Biochemical Pharmacology 2008 Jan 1;75(1):218-65

Gass JT, Olive MF

The past two decades have witnessed a dramatic accumulation of evidence indicating that the excitatory amino acid glutamate plays an important role in drug addiction and alcoholism. The purpose of this review is to summarize findings on glutamatergic substrates of addiction, surveying data from both human and animal studies. The effects of various drugs of abuse on glutamatergic neurotransmission are discussed, as are the effects of pharmacological or genetic manipulation of various components of glutamate transmission on drug reinforcement, conditioned reward, extinction, and relapse-like behavior. In addition, glutamatergic agents that are currently in use or are undergoing testing in clinical trials for the treatment of addiction are discussed, including acamprosate, N-acetylcysteine, modafinil, topiramate, lamotrigine, gabapentin and memantine. All drugs of abuse appear to modulate glutamatergic transmission, albeit by different mechanisms, and this modulation of glutamate transmission is believed to result in long-lasting neuroplastic changes in the brain that may contribute to the perseveration of drug-seeking behavior and drug-associated memories. In general, attenuation of glutamatergic transmission reduces drug reward, reinforcement, and relapse-like behavior. On the other hand, potentiation of glutamatergic transmission appears to facilitate the extinction of drug-seeking behavior. However, attempts at identifying genetic polymorphisms in components of glutamate transmission in humans have yielded only a limited number of candidate genes that may serve as risk factors for the development of addiction. Nonetheless, manipulation of glutamatergic neurotransmission appears to be a promising avenue of research in developing improved therapeutic agents for the treatment of drug addiction and alcoholism.

Discussion Thread

Category Addiction Documents 
 
Suggest other entries I might like
Submitted by Jatelka Find all entries from this user
06-06-2008
966.66 Kbytes Hits 6
 

 
Category
 
Forum Jump

Sitelinks: Site Functions:

All times are GMT +1. The time now is 22:32.


Copyright: Substance Information Network 2003 - 2009, All rights reserved